5:42 PM
 | 
May 29, 2008
 |  BC Extra  |  Company News

GSK submits Rezonic NDA

GlaxoSmithKline (LSE:GSK; NYSE:GSK) said it submitted an NDA last week for an IV and an...

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >